
==== Front
Curr Sex Health Rep
Curr Sex Health Rep
Current Sexual Health Reports
1548-3584
1548-3592
Springer US New York

386
10.1007/s11930-024-00386-1
Article
From Parental Behavior to Sexual Function: Recent Advances in Oxytocin Research
Dale II Joseph 24
Harberson Mitchell T. 12
http://orcid.org/0000-0001-7482-9215
Hill Jennifer W. JenniferW.Hill@utoledo.edu

123
1 https://ror.org/01pbdzh19 grid.267337.4 0000 0001 2184 944X Center for Diabetes and Endocrine Research, University of Toledo College of Medicine, Toledo, OH USA
2 https://ror.org/01pbdzh19 grid.267337.4 0000 0001 2184 944X Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH USA
3 https://ror.org/01pbdzh19 grid.267337.4 0000 0001 2184 944X Department of Obstetrics and Gynecology, University of Toledo College of Medicine, Toledo, OH USA
4 https://ror.org/01pbdzh19 grid.267337.4 0000 0001 2184 944X Department of Biology, University of Toledo College of Medicine, Toledo, OH USA
11 5 2024
11 5 2024
2024
16 3 119130
2 5 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Purpose of Review

Oxytocin plays many diverse roles in physiological and behavioral processes, including social activity, parental nurturing, stress responses, and sexual function. In this narrative review, we provide an update on the most noteworthy recent findings in this fascinating field.

Recent Findings

The development of techniques such as serial two-photon tomography and fiber photometry have provided a window into oxytocin neuroanatomy and real-time neuronal activity during social interactions. fMRI and complementary mapping techniques offer new insights into oxytocin's influence on brain activity and connectivity. Indeed, oxytocin has recently been found to influence the acquisition of maternal care behaviors and to mediate the influence of social touch on brain development and social interaction. Additionally, oxytocin plays a crucial role in male sexual function, affecting erectile activity and ejaculation, while its role in females remains controversial. Recent studies also highlight oxytocin's interaction with other neuropeptides, such as melanin-concentrating hormone, serotonin, and arginine vasopressin, influencing social and affective behaviors. Finally, an update is provided on the status of clinical trials involving oxytocin as a therapeutic intervention.

Summary

The exploration of oxytocin's complexities and its interplay with other neuropeptides holds promise for targeted treatment in various health and disease contexts. Overall, these findings contribute to the discovery of new and specific pathways to allow therapeutic targeting of oxytocin to treat disorders.

Keywords

Oxytocin
Paraventricular Hypothalamic Nucleus
Social Behavior
Sexual Behavior
Maternal Behavior
Neuroanatomy
http://dx.doi.org/10.13039/100000002 National Institutes of Health T32GM144873 Dale II Joseph http://dx.doi.org/10.13039/100006955 Office of Extramural Research, National Institutes of Health HD104418 HD104418 Harberson Mitchell T. Hill Jennifer W. issue-copyright-statement© Springer Science+Business Media, LLC, part of Springer Nature 2024
==== Body
pmcIntroduction

Oxytocin is a well-known and highly-studied nonapeptide hormone produced by neurons in the supraoptic nucleus (SON) and the paraventricular nucleus of the hypothalamus (PVH). Magnocellular oxytocin neurons in these areas project to the posterior pituitary gland where they release oxytocin into circulation [1]. The most well-known function of oxytocin is inducing contractions in the uterus during labor and in the breast tissue during breast feeding. Oxytocin can also be released centrally in the brain to modulate the activity of neurons and neural circuits to regulate a range of social and non-social processes. Oxytocin research has primarily focused on its regulation of social behaviors such as parental nurturing, pair bonding, partner preference, sensory processing, empathy, and sexual function [2, 3]. How oxytocin modifies such a large range of social behaviors is a major open question. One of the dominant hypotheses, the “social salience” hypothesis, claims that oxytocin does not promote prosocial behaviors but rather increases the salience of social stimuli by acting on the mesolimbic dopamine system[4]. The primary evidence for this hypothesis is that oxytocin action is context-specific rather than unidirectional in its actions. For example, oxytocin increases love, trust, and empathy only toward in-group members while promoting aggression toward out-group members[5, 6]. Inconsistencies in the literature are also explained by oxytocin action being sex-specific[7, 8], species-specific[9, 10], and specific to the stage of development[11]. Despite this complexity, scientists have used advances in genetic, molecular, and anatomical biology to help understand the underlying mechanisms controlling behaviors. As detailed below, these studies represent a major advance in our understanding of oxytocin.

New Neuroanatomical Insights

New advances in genetic models, technology, and computer software [12] have enhanced our understanding of oxytocinergic neuroanatomy, activity, and interactivity with other neuronal cell types. Recently, Son and colleagues have used whole-brain mapping techniques to visualize oxytocin's distribution, projections, and overlap with oxytocin receptor (OXTR) expression in mice [13••]. The largest clusters of oxytocin neurons were found in the PVH, SON, accessory nuclei (AN), and the often-overlooked tuberal nucleus (TU), which had nearly as many neurons as the PVH. Imaging the separate projections of these four nuclei yielded data that is well-supported by other recent publications [14, 15]. The PVH projected widely to nine functional circuits; the AN and SON may regulate these circuits through their projections to the PVH. The TU had no long-range projections. Interestingly, most projection areas had reciprocal connections with oxytocinergic circuits. Although most oxytocin neurons project to midbrain and hindbrain regions, OXTR is expressed primarily in cortical regions. Indeed, when the oxytocin projectome data were compared to whole-brain OXTR expression, no correlation was found except in the thalamus and medulla. Furthermore, this publication found oxytocin fibers contacting the surface of the lateral, third, and fourth ventricles [13••]. Taken together, these results support the well-documented hypothesis that oxytocin action is partially mediated through transmission into the cerebrospinal fluid (CSF) [16]. More specifically, oxytocin secretion into the CSF of the lateral ventricle has been found to be important for its actions in the cerebral cortex[17]. This mechanism may explain how oxytocin interacts with the high cortical expression of OXTR found by Son and colleagues. However, other studies have found most regions that express OXTR have at least a small number of oxytocinergic projections[9]; therefore, oxytocin action is likely mediated through both CSF and direct transmission. The non-ventricular oxytocin projections that seemingly have no local OXTR expression could be instances of oxytocin acting on other receptors such as vasopressin receptors[18] or TRPV1 receptors[19]. An interesting alternative hypothesis was proposed by Grinevich and coworkers that states these oxytocinergic projections may be secreting glutamate from these synapses while secreting oxytocin non-synaptically (i.e. somatodendritically)[20]. Indeed, evidence suggests the fear-related behavioral effects of oxytocin neurons are mediated through synaptic glutamate, not oxytocin[21].

Zhang and colleagues recently used serial sectioning tomography to image magnocellular oxytocin neurons [22] at a higher resolution than previously performed [23]. Excluding their pituitary projections, these neurons project to cortical (piriform cortex, auditory cortex) and subcortical (amygdala, nucleus accumbens, caudoputamen, lateral septum) regions. When these magnocellular neurons were activated or inhibited, they increased or decreased social investigation and interaction, respectively [22]. These findings are reinforced by another study using tissue clearing to image oxytocin and vasopressin populations in the developing mouse brain [24]. Overall, these studies provide a clear picture of the major oxytocin circuits that may regulate attention, threat detection, sleep/wake, pain, sensory motor regulation, metabolism, learning, memory, reward, and reproductive functions. In future studies, these mapping techniques could be used to image whole-brain activation levels of oxytocin neurons using the expression of c-fos; for example, one study imaged neural activation during social recognition [25].

One of the major drawbacks of whole-brain mapping techniques is that they only capture a snapshot of neuroanatomy and neural activity. Therefore, these studies are nicely complemented by fMRI in mice, which can capture whole-brain dynamic changes in activity and connectivity [12]. For example, one recent study, which used both pharmacological MRI and tissue clearing with c-fos staining, found differences in brain activity in the Cntnap2 KO mouse model of autism spectrum disorder [26]. Differences in functional connectivity were also found using resting-state MRI. Interestingly, deficits in brain activity and connectivity were reversed after i.p. injection or endogenous release of oxytocin. The nucleus accumbens (NAc) was one such region that saw this reversal in brain activity and connectivity, so it was further studied for its role in social salience and reward. Injection of an oxytocin agonist into the NAc or activation of oxytocin axons in the NAc increased social interaction time in Cntnap2 KO mice, showing oxytocin action in the NAc promotes sociality in this context [26]. Overall, whole-brain activation and connectivity studies have further reiterated the importance of oxytocin action in the nucleus accumbens, which further bolsters the “social salience” hypothesis.

One of the most powerful imaging techniques for mechanistic studies is fiber photometry, or the use of an optic fiber to measure fluorescence as an indicator of activity. For example, genetically encoded indicators of calcium—such as the GCaMP6 proteins—fluoresce during neuronal activation and offer real-time tracking of activity in mice. Tang and colleagues tracked oxytocin neuronal activity during social interaction in freely moving mice using fiber photometry and tetrode measurements [27•]. Social touch activated oxytocin neurons to the greatest extent when the mouse was either crawling on top of another animal or being crawled on. Interestingly, social touch increased c-fos in parvocellular oxytocin neurons but not magnocellular oxytocin neurons. The parvocellular neurons in the PVH were previously found by the authors to project to the SON and act on magnocellular oxytocin neurons to mediate nociception [28]. Using chemogenetics, activation of parvocellular oxytocin neurons projecting to the SON increased the free social interactions in mice and activity in magnocellular neurons, while inhibition had the opposite effect. These results suggest social touch releases oxytocin by first activating parvocellular oxytocin neurons in the PVH, which then activate magnocellular oxytocin neurons in the SON [27•]. Another study tracked the activity of hundreds of individual PVH oxytocin neurons in head-fixed mice by imaging GCaMP6 via two-photon microscopy [29]. Two-photon microscopes are known for superior tissue penetration yet are not powerful enough to reach the hypothalamus; thus, the authors used the cutting-edge approach of mounting a micro gradient refractive index lens (GRIN) to the top of the mouse head to improve tissue penetration. When exposed to a social stimulus (a juvenile mouse), a greater proportion of oxytocin neurons were activated, and a lower proportion of oxytocin neurons were inhibited compared to a non-social stimulus (a toy mouse). Subpopulations of oxytocin neurons were activated by both stimuli or had opposing responses to both stimuli—for example, being activated by social stimuli and inactivated by non-social stimuli. Interestingly, the subpopulations with opposing responses had low spontaneous activity while populations activated by both stimuli had high spontaneous activity. These results suggest a subpopulation of PVH oxytocin neurons with low spontaneous activity responds to social stimuli [29]. Overall, real-time tracking of oxytocin neuronal activity using fiber photometry has improved our understanding of how oxytocin neurons are activated and how their activation regulates social behavior. Future studies could use fluorescence miniscopes mounted above the GRIN lens to track hundreds of oxytocin neurons in freely moving animals [12, 30, 31]. Other novel technologies such as a genetically encoded oxytocin sensors are also being rapidly adopted for pathway analysis [32, 33].

Recently Identified Neuropeptide Interactions

New oxytocin research has provided insight into the dynamic interactions of this peptide with other neuropeptide pathways. Among these, the interplay between oxytocin, melanin-concentrating hormone (MCH), serotonin, and vasopressin is highlighted in recent studies on social and affective behaviors.

MCH is a peptide neurotransmitter produced in the lateral hypothalamus and zona incerta that is perhaps best known for promoting appetitive behaviors and regulating arousal [34]. Like oxytocin, MCH regulates sexual [35], social [36], and maternal behaviors [37, 38], and has recently been found to be downstream of oxytocin signaling [39]. Indeed, MCH neurons receive oxytocinergic inputs from the PVH, express OXTR on nearly 60% of cells[39], and respond to oxytocin with increased activity [40]. Recently, oxytocin's effects on repetitive behaviors and social recognition have been found to be mediated by MCH. Sanathara and colleagues found that oxytocin or MCH treatment of male mice reduced marble burying, a measure of repetitive behavior. No additive effect was seen when oxytocin and MCH were given together. Further, the oxytocin-driven increase in marble burying was blocked by co-treatment with an MCH receptor antagonist. Another study found mice have impaired social recognition when OXTRs were knocked out only in MCH neurons. While wild-type (WT) mice spent more time with novel mice, OXTR-MCHKO mice spent an equal amount of time with familiar and novel mice [41]. A similar OXTR-MCHKO model was used to determine that oxytocin signaling on MCH neurons regulates mood and depressive behavior [42]. Taken together, these results raise the possibility that some of oxytocin's therapeutic effects on symptoms of autism spectrum disorder—including reduced repetitive behaviors and improved social recognition [39, 41]—are mediated by MCH.

Serotonin is also involved in the effects of oxytocin on anxiety and social reward. Serotonin is widely expressed in the raphe nuclei (RN). The RN receives input from PVH oxytocin neurons [13••, 43] and expresses OXTR in rodents [44]. Oxytocin increases the availability of serotonin receptors in the amygdala, insula, and hippocampus in primates and humans and induces serotonin release in those same regions in primates [45, 46]. Yoshida and colleagues found that oxytocin treatment promoted the release of serotonin in the median raphe nucleus and increased the time spent in the center of an open-field test, indicating less anxiety. The decrease in anxiety-like behavior was blocked when oxytocin was co-administered with an OXTR antagonist [44]. Another study found that oxytocin can mediate social reward by inducing neuroplastic changes in the caudal nucleus accumbens. This effect depended on oxytocin signaling in serotonin neurons in the dorsal raphe [47]. While these studies clarify that oxytocin regulates serotonin neurons, one recent paper found the converse; serotonin regulates oxytocin neuron activity when a mouse pup first interacts with its mother [48•]. Maternal odors not only activated oxytocin neurons in the infant but serotonin neurons in the RN as well. Mice lacking the tryptophan hydroxylase 2 enzyme, necessary for serotonin synthesis, showed impaired maternal affiliation, which was restored by oxytocin treatment. Lastly, these deficits were also rescued by the activation of oxytocin neurons in the PVH or serotonergic projections to the PVH [48•]. Overall, these results suggest that the reciprocal connections between RN serotonin neurons and PVH oxytocin neurons influence anxiety, social reward, and maternal affiliation.

Vasopressin and oxytocin evolved from the same precursor gene that was duplicated over 600 million years ago and share seven out of nine amino acids [18]. Further, the OXTR has 85% sequence homology with the most prominent vasopressin receptor (V1aR). Indeed, crosstalk between these hormones has been discovered [18, 49]. Peripheral effects of oxytocin, such as reducing heart rate and body temperature [50] and inducing ejaculatory contractions, are blocked by V1aR but not OXTR antagonists [18]. In addition, the central effects of oxytocin, such as induction of flank marking (a rodent dominance behavior where odors are secreted from the flank gland) are blocked by V1aR antagonists [18]. The extent to which this crosstalk influences study results, endogenous hormone action, or exogenous hormone medications is an area of recent interest to the field. An ex vivo study found that both hormones have the highest affinities for their cognate receptors; in fact, oxytocin had a 100-fold higher affinity for OXTR over V1aR, and vasopressin had a sevenfold higher affinity for V1aR over OXTR [51]. The crosstalk in this study is less than previously reported [18] and has been supported by follow-up studies in other species[52]. Another set of studies found consistent crosstalk among receptors from different primate species and their oxytocin variants, but vasopressin showed the highest efficiency and potency for V1aR activation [52, 53]. Lastly, one study compared oxytocin and vasopressin fiber density with V1aR and OXTR binding densities in key brain regions in the rat. The medial amygdala, bed nucleus of the stria terminalis (BNST), mPOA, and periaqueductal gray (PAG) stood out as the nuclei with the greatest overlap and therefore were concluded to be most susceptible to crosstalk [54]. Similar interactions between the oxytocin and vasopressin systems may occur peripherally in pregnant women with elevated oxytocin levels [55]. Thus, when studying oxytocin, the possibility of V1aR activation should be considered. For example, endogenous oxytocin can still activate V1aR in OXTR KO animals, so models with both OXTR KO and endogenous oxytocin blockade may be valuable for further understanding this crosstalk. Action at vasopressin receptors must also be considered when analyzing the effects of medications that can raise oxytocin to hyper-physiological levels [56, 57]. However, the exact magnitude of crosstalk will be difficult to quantify until consistent methods for measuring oxytocin centrally and peripherally can be established [58].

New Insights into Maternal Behavior

Oxytocin triggers maternal behaviors, including the ability of a mouse dam to recognize and respond to the calls of her pups [59]. In mice, oxytocin enables maternal recognition of pup distress by acting in the auditory cortex. The Froemke lab has shown a high concentration of oxytocin neuronal projections in the left auditory cortex [60, 61]. They found dams receiving oxytocin in the left auditory cortex showed pup retrieval and maternal behaviors earlier than saline-infused dams. Similar results were found with optogenetic stimulation of the same region. Activity in these oxytocin neurons led to changes in auditory cortex firing in response to pup calls, which allowed mice to recognize pup calls and facilitated maternal care.

Building on this research, Valtcheva and colleagues have recently used chemogenetics to show that oxytocin allows dams to learn how to respond to pup auditory calls [62]. They monitored the ability of virgin mice to show alloparenting, which is providing parental care to pups that are not their own. Virgin mice co-housed with an experienced dam and pups responded to pup auditory calls roughly 50% quicker than virgin females housed with pups alone. This finding shows the importance of social learning, whereby the experienced dam demonstrated appropriate responses to pup calls for the virgin female. Interestingly, pup retrieval in virgin and experienced mice triggered increased activity in oxytocin neurons. The researchers then compared normal mice and Oxy-cre mice injected with an inhibitory designer receptor exclusively activated by designer drugs (DREADD) to suppress the activity of oxytocin neurons in the PVH. When oxytocin neurons were inactivated, virgin females did not effectively respond to pup vocal signals over a 4-day testing period even when housed with an experienced dam. Thus, social learning of alloparenting requires functional oxytocinergic neurons in the PVH. Since the females had physical contact with the pups during their calls, the studies did not test if the auditory signal of the pups alone triggered oxytocin signaling. It is therefore unclear whether the oxytocin signaling modulating parental behavior was activated through touch or sound.

Social touch is essential for normal mammalian brain development in young organisms. Harry Harlow established the importance of social touch in his classic studies showing young macaques preferred spending time with surrogate mothers made of soft terrycloth to wire ones that provided food [63]. Further, monkeys lacking maternal touch exhibited anxiety-like behaviors and did not interact normally with their peers [64]. In humans, early positive somatosensory interaction such as cuddling, breastfeeding, and exposure to the scent of their parents is linked to a decreased chance of adolescent anxiety disorders [65]. A recent study in mice used a machine to mimic maternal touch and licking to examine the effects of tactile touch on juveniles [65]. Social touch increased the spontaneous firing rate of oxytocin neurons in acute ex vivo slices. Oxytocin firing induced by tactile touch also promoted increased social interaction in a substance P-dependent manner. Indeed, a group of periaqueductal gray substance P-producing, Tac1-expressing neurons known primarily for their role in nociception [66••] were found to send monosynaptic excitatory projections to the PVH. Social touch increased their firing rates, while their activation induced social interaction. The authors propose these neurons convey the experience of pleasant social touch via oxytocin neuron activation to elicit social behavior [65]. Overall, these studies serve as an important stepping-stone in the development and use of oxytocin for clinical conditions that cause social deficiencies. Indeed, a clinical trial, described later, has also recently investigated the role of oxytocin in human social touch.

Advances in the Sexual Function Field

Oxytocin's neurophysiological influence extends to a variety of well-established roles, including male sexual physiology and function. These actions involve communication with key brain regions, such as the BNST and PVH. Recent studies have reinforced the importance of oxytocin in male sexual function and interrogated the sexual dimorphism of this system.

In the 1980s, Argiolas and colleagues found that intracerebroventricular injections of oxytocin induced penile erections in rats [67]. Later studies showed administering oxytocin to the medial preoptic area (mPOA), PVH [68], ventral tegmental area [69•], or the BNST[70] elicited erectile effects in mice and triggered c-fos expression in these regions. OXTR antagonists blocked the effect of direct oxytocin injection into the BNST, potentially by acting on glutamatergic neurons [8, 68, 69•, 71]. Activation of the OXTR in the PVH leads to an influx of calcium and activation of nitric oxide synthase in the brain that promotes erectile activity [8, 68, 69•, 71]. Another proposed pathway for the erectile effects of oxytocin involves the activation of serotoninergic lumbosacral spinal neurons that send signals directly to the pudendal nerves facilitating penile erection. This mechanism is supported by findings showing internasal administration of oxytocin in males increases 5-HT receptor activity in the lumbosacral spinal cord [46, 72, 73]. Oxytocin may not be essential for normal erectile function and sexual function in male rats, however, because rats lacking the oxytocin gene show normal sexual activity and receptivity [69•, 74]. Alternatively, its functional importance may be masked by the functional redundancy of other neuropeptides in this model [75].

Premature ejaculation is the most common cause of male sexual dysfunction, affecting up to 30% of men worldwide[76]. Lumbar spinothalamic cells that trigger ejaculation in rats send signals to and receive them from hypothalamic oxytocin neurons [68]. In addition, peripheral effects of oxytocin on ejaculation have been hypothesized based on data showing the OXTR is present in the human epididymis and mediates contractile activity necessary for seminal release [77]. Recently, Beatrix Stadler and colleagues showed that oxytocin elicited a large concentration-dependent tonic response in the muscle of the corpus spongiosum, bladder neck, and prostate urethra [78]. In ex vivo preparations of these tissues treated with a strong OXTR antagonist, oxytocin could still elicit a tonic effect in penile tissue. The researchers found this action required oxytocin binding to the vasopressin receptor subtype V1B in these tissues. Others have found that oxytocin administered systemically reduced the time taken for the first mount, intromission, and ejaculation in males [79]. These findings suggest systemic oxytocin signaling can improve ejaculation efficiency [15, 78].

Some oxytocin neurons in the PVH express the melanocortin 4 receptor (MC4R) [80], whose activation can stimulate oxytocin release [81]. Notably, Peñagarikano and co-authors (2015) discovered that inducing the release of oxytocin with a specific MC4R agonist alleviated social deficits in the Ctnap2 transgenic mice [82]. Thus, inducing oxytocin release via exogenous drugs can mimic the actions of endogenous oxytocin in mice. New data from our lab suggest MC4R activation also leads to oxytocin neuron activation during ejaculation [83]. Transgenic mice lacking the MC4R in all cells showed delayed ejaculation compared to WT mice. This phenotype was not seen in mice with the MC4R expressed only on oxytocin neurons, demonstrating sufficiency of oxytocin neurons for mediating this effect. Importantly, the groups were matched at young ages to control for the effects of obesity. Thus, MC4R-mediated melanocortin signaling on oxytocin neurons promotes normal ejaculation independent of the male's metabolic status. These studies demonstrate that melanocortin-responsive oxytocin pathways are sufficient for ejaculatory function, but do not rule out the existence of additional, redundant pathways.

A comprehensive understanding of oxytocin's involvement in sexual function will provide potential avenues for therapeutic advances for conditions such as erectile and ejaculatory dysfunction. Central treatments for erectile function are not currently being pursued but could be an avenue for treatment when psychogenic erectile dysfunction is suspected [84]. Unraveling the intricacies of this neurocircuitry will pave the way for better treatment choices for men dealing with sexual dysfunction.

Oxytocin may facilitate female sexual function and receptivity as well. In female rodents, mating increases c-fos expression in oxytocin neurons [85] and oxytocin levels in the PVH [86]. Administration of oxytocin into either the medial preoptic area (mPOA) or the ventromedial hypothalamus (VMH) improves sexual receptivity [87, 88]. Female mice lacking oxytocin show decreased, but not eliminated, lordosis behavior [89, 90]. In prairie voles, oxytocin increases sexual receptivity in sexually naïve but not experienced females [91, 92].

Whether these results translate to humans is unclear. Oxytocin has the potential to improve sexual function in women, in that increased blood oxytocin levels accompany sexual arousal and orgasm [93]. However, intranasal oxytocin was recently found to have no effect on sexual drive, arousal, or orgasm during self-stimulation in a laboratory setting, nor did it influence physiological parameters such as vaginal blood volume [94]. However, a similar study where participants had sex with their partners at home found that women were more relaxed, better at communicating their sexual desires, and better at empathizing with their partner after intranasal oxytocin treatment [95]. Here is yet another example of oxytocin promoting social salience of a stimulus. Thus, oxytocin in women may not affect sexual desire, arousal, or orgasm, but instead enhance overall experience by promoting partner bonding and the social benefits of sex. This hypothesis is supported by the role of mating-induced oxytocin release in the formation of pair bonds in monogamous species [96] and the importance of oxytocin release in the formation and maintenance of romantic relationships in humans [97, 98].

Translating Oxytocin Research from Bench to Bedside

As we have seen, mechanistic studies of oxytocin action on brain pathways in animal models have advanced substantially with new techniques to manipulate and measure neuronal activity. These approaches have increased our understanding of the pathways involved in the behavioral effects of centrally administered oxytocin in animals. The encouraging behavioral effects of oxytocin in animals have captured widespread interest. Many are intrigued by the clinical potential of oxytocin as a treatment for psychopathologies related to socio-emotional dysfunction, including autism spectrum disorders, anxiety disorders, social phobia, and schizophrenia [99–101]. Human research relies on non-invasive approaches like observational studies on oxytocin and social behavior, translational studies on patients with social behavior disorders, and intervention studies with peripheral oxytocin administration. Clinical trials exploring the administration of oxytocin have yielded mixed results, and the effectiveness of oxytocin in various contexts is still an area of ongoing research [102–104]. Several different approaches have been taken to leverage the power of oxytocin in clinical applications.

As intracerebral administration is impractical in humans, researchers have turned to intranasal administration to manipulate oxytocin levels in the brain. The application of this method assumes that when oxytocin is administered intranasally, it raises oxytocin levels in the central nervous system through nose-to-brain pathways. Intranasal administration is believed to induce psychological and behavioral effects by engaging central oxytocin receptors. The advantages of this pain-free, non-invasive, and direct administration are clear. However, the absence of observable effects in both healthy and clinical populations following intranasal oxytocin administration [105–108] has prompted consideration about the reliability of earlier reported positive effects [102, 103, 109]. One important finding in translational/clinical research on oxytocin in recent years was the unsuccessful phase II study using intranasal oxytocin to address social behavioral deficits in autism [104]. A notable critique of this trial was that, based on the social salience hypothesis, oxytocin would not be expected to have a therapeutic impact unless it was administered within a therapeutic context [110]. Indeed, a preliminary study discovered that intranasal oxytocin was beneficial, but only when administered alongside a positive social environment (as an adjunct to therapy) [111]. More recently, a study found that long-term intranasal oxytocin administration triggered the body's natural oxytocin system [112]. This research suggests that combining oxytocin treatment with social interaction (such as psychosocial therapy) could enhance the body's natural oxytocin feedback loop.

Despite extensive research, the question of whether intranasal oxytocin administration is capable of accessing the brain has not been resolved [113]. For example, intranasal administration in oxytocin knockout mice, who cannot produce oxytocin, increased levels in brain tissue [114]. While peripheral oxytocin appears to reach the brain via transport across the blood–brain barrier (BBB) in both rodents and primates [57, 115], only a small percentage of administered oxytocin crosses the barrier into the CSF (up to 0.005%) even when given at supraphysiological levels [113]. Moreover, CSF measures of oxytocin may not represent oxytocin's action within brain tissue, where oxytocin receptors are located. An alternative route of brain penetration for intranasal oxytocin is convective bulk transport in the CSF that flows within the perivascular spaces around the olfactory and trigeminal nerves [116, 117]. Recent research in rats showed increased detection of an oxytocin receptor radiotracer in the trigeminal and olfactory nerves and olfactory bulbs of rats after intranasal administration compared to intravenous administration [118]. Uptake into the brain via circumventricular organs lacking the BBB but expressing OXTR requires further investigation [119]. Only a single human study with a small sample size found increased oxytocin levels in CSF following intranasal oxytocin administration [120]. Additional study of the brain penetrance of intranasal oxytocin in humans is critical for determining its value as a therapeutic [121]. Looking ahead, exploring the development of oxytocin agonists or antagonists capable of crossing the BBB may offer a better alternative than intranasal administration.

Dysregulation of oxytocin has also been hypothesized to play a role in the pathophysiology of schizophrenia. Goh and colleagues hypothesize that decreased oxytocin dysregulates reward signaling and improperly assigns emotional salience, which leads to paranoia and social isolation [122]. In support of this hypothesis, several studies have found both positive and negative symptoms of schizophrenia negatively correlate with serum oxytocin levels [122]. Many studies have tested oxytocin as a treatment for schizophrenia alongside antipsychotics. Although some studies have found oxytocin improves the positive and negative symptoms of schizophrenia, other studies have found no significant difference from placebo [122]. Separately, oxytocin could also be relevant for the treatment of post-traumatic stress disorder. MDMA has been found to improve symptoms for post-traumatic stress disorder (PTSD), these positive effects have been speculated to be mediated through oxytocin signaling [123]. Because the oxytocin system is involved in a wide array of neural processes, it remains an interesting potential therapeutic for a multitude of neuropsychiatric conditions.

Interestingly, a clinical trial called "The Effects of Oxytocin Treatment on Social Touch" led by Dr. Qin Li, of the University of Electronic Science and Technology of China has recently investigated the use of oxytocin to increase the pleasure experienced during social touch in humans [48•]. The study was done in a randomized manner with placebo drug controls. The trial specifically sought to determine the best administration route for oxytocin, oral or intranasal, to affect pleasure perceived by gentle touch. Touch sensations activate different nerve fibers depending on the strength of skin contact, leading to the activation of separate sensory pathways. They therefore sought to determine if oral or intranasal treatment affected the subjective experience of gentle vs. forceful touch during massage therapy. They found that both administration routes increased the plasma concentration of oxytocin and the perceived pleasantness of the gentle massage. The perception of the forceful massage was not altered [48•]. The study did not explain if a central or peripheral action of oxytocin drove the effects they observed, and a potential mechanism of action for oral oxytocin is lacking [124]. OXTRs are widely present in peripheral organs like the heart, skin, intestinal tract, and autonomic nervous system. Peripheral oxytocin has numerous effects [125–127]. For instance, peripheral oxytocin increases insulin and glucagon secretion [128], regulates gastric motility [129], activates vagal afferent neurons [130], and increases heart rate variability [131]. Oxytocin action in the periphery is often linked to its central action; for example, oxytocin promotes birth and breast feeding peripherally but also maternal behaviors centrally [15]. Thus, peripheral oxytocin may regulate perception of social touch through actions on peripheral organs [119]. This suggestion is supported by the aforementioned studies that found social touch activates oxytocin neurons in the PVH [132] and is in accordance with the social salience hypothesis that states central oxytocin increases salience for social stimuli. Lastly, social touch is valuable for human development, the formation of relationships, and social reward; thus, enhancing social touch in individuals with autism spectrum disorder (ASD) could provide another therapeutic approach [133].

Clinical trials studying oxytocin are likely to continue and advance to other areas of disease treatment as our understanding of its pharmacological effects strengthens. To date, clinical studies have not found oxytocin toxicity or any major side effects after administration, regardless of the dosages or routes of administration used (IV, Oral, Intranasal) [134, 135]. It is possible, however, that when oxytocin is administered over an extended period, it may lead to adverse effects. In rodents, chronic oxytocin treatment is associated with changes in social behaviors and the expression of OXTRs within the brain [136–139]. Additionally, individuals with pre-existing heart conditions might be at a higher risk of experiencing negative effects from the cardiovascular actions of oxytocin [134, 140, 141].

Overall, current evidence regarding the effect of exogenous oxytocin on human social behavior has been judged to be weak [142]. Several specific concerns have been raised regarding this body of research in humans, including the heterogeneity of findings, the lack of replication of results, and the need for detailed dose–response studies [143]. In addition, approaches used were exploratory and critically underpowered, with oxytocin randomized controlled trials reported as having 16% statistical power on average [143]. There is a clear need to calculate precise sample size estimates when planning studies [144, 145]. Recent articles advise the use of standardized methods and study pre-registration to improve oxytocin measurement precision [58, 113, 145]. These steps may help the field overcome problems with methods and reproducibility and lead to a clear picture of how oxytocin affects human behavior.

An alternative to exogenous oxytocin administration is inducing endogenous oxytocin release within established neural circuits. In particular, melanocortin receptor agonists hold great potential for stimulating the endogenous oxytocin system, as previously mentioned. Oxytocin neurons in the PVH and SON express MC4R [80] and are activated by MC4R agonists [81]. Both central and peripheral administration of MC4R agonists increases oxytocin levels in the hypothalamus [146, 147]. One of the most recent advances in female sexual health was the FDA approval of the MC4R agonist bremelanotide to treat hypoactive sexual desire disorder. Not only do data in rats support bremelanotide's efficacy [148], but bremelanotide's effects may be partially mediated by oxytocin neurons. Recently, our lab found that knock out of MC4R reduced sexual receptivity in female mice independent of body weight [80]. Interestingly, expression of MC4R only in Sim1 neurons—which are prominently found in the PVH—rescued sexual receptivity. However, when MC4R was only expressed in oxytocin neurons—which are a subset of Sim1 neurons—sexual receptivity was not fully normalized [80]. Therefore, oxytocin mediates some but not all the pro-sexual effects of melanocortins in female mice. The sexually dimorphic roles of the oxytocin and melanocortin systems in sexual behavior and function deserve further study.

In accordance with the capacity for melanocortins to induce oxytocin release, preclinical studies have found melanocortin treatment improves social behavior in rodent models with social deficits. First, in a maternal immune activation mouse model of ASD, melanocortin treatment over 7 days improved their sociability index to the same level as WT mice[149]. Second, the CNTNAP2 KO mouse model of ASD had a full recovery in social interaction after treatment with a melanocortin agonist[82]. Third, a neonatal isolation model in prairie voles decreased time spent with their partner in a preference test; preference for their partner was restored after treatment with melanocortins[150]. Interestingly, similar to oxytocin, the melanocortin-induced brain activation is different in social vs non-social contexts and is affected by OXTR antagonists[151]. Overall, melanocortins are brain penetrant, safety-tested drugs that could be used for treatment of ASD due to their action on oxytocin neurons.

Conclusions

In conclusion, oxytocin research continues to uncover new roles for this peptide in diverse biological and behavioral processes. From its classical functions in labor and lactation to its involvement in social behaviors, parenting, and sexual functions, oxytocin is a central player in shaping mammalian physiology. Advances in genetic models, neuroanatomy mapping, and innovative technologies have provided unprecedented insights into the spatiotemporal regulation of oxytocin and its dynamic interactions with other neuropeptide pathways. Notably, research into oxytocin's interplay with MCH, serotonin, and vasopressin offers valuable perspectives on shared regulatory controls over social and affective behaviors. These advances in oxytocin provide support for the social salience hypothesis and help to tease apart the complex web of oxytocin’s interactions. These advances also pave the way for potential therapeutic interventions. The increasing array of techniques and resources available, along with advancements in translational research [187, 188] may allow the quality of study results to continue to improve in the coming years. Despite recent studies that found no effect of intranasal oxytocin treatment in adolescence with ASD [104], there is justified optimism regarding the potential for oxytocin-based treatments for disorders linked to social deficits. Indeed, studies have found intranasal oxytocin to promote endogenous release [112] and to be an effective adjunct for psychosocial therapy [111]. Therefore, further basic and translational research into this pivotal neurohormone's roles in health and disease is critical.

Acknowledgements

This work was supported by National Institutes of Health grant HD104418 to JWH. JD received support from NIH project 5T32GM144873.

Author Contributions

JWH conceptualized the review in response to the journal invitation, all authors contributed to the literature search and analysis, MTH and JD drafted the work, and all authors critically revised the manuscript. All authors read and approved the final version.

Declarations

Competing Interests

The authors have no relevant financial or non-financial interests to disclose.

Human/Animal Studies Informed Consent Statement

This article does not contain any studies with human or animal subjects performed by any of the authors.

Joseph Dale II and Mitchell T. Harberson are joint first authors.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References:

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. Wang P Neural Functions of Hypothalamic Oxytocin and its Regulation ASN Neuro 2022 14 17590914221100706 10.1177/17590914221100706 35593066
Wang P, et al. Neural Functions of Hypothalamic Oxytocin and its Regulation. ASN Neuro. 2022;14:17590914221100706.35593066 10.1177/17590914221100706
2. Froemke RC Young LJ Oxytocin, Neural Plasticity, and Social Behavior Annu Rev Neurosci 2021 44 359 381 10.1146/annurev-neuro-102320-102847 33823654
Froemke RC, Young LJ. Oxytocin, Neural Plasticity, and Social Behavior. Annu Rev Neurosci. 2021;44:359–81.33823654 10.1146/annurev-neuro-102320-102847
3. Wei D Talwar V Lin D Neural circuits of social behaviors: Innate yet flexible Neuron 2021 109 10 1600 1620 10.1016/j.neuron.2021.02.012 33705708
Wei D, Talwar V, Lin D. Neural circuits of social behaviors: Innate yet flexible. Neuron. 2021;109(10):1600–20.33705708 10.1016/j.neuron.2021.02.012
4. Shamay-Tsoory SG Abu-Akel A The Social Salience Hypothesis of Oxytocin Biol Psychiatry 2016 79 3 194 202 10.1016/j.biopsych.2015.07.020 26321019
Shamay-Tsoory SG, Abu-Akel A. The Social Salience Hypothesis of Oxytocin. Biol Psychiatry. 2016;79(3):194–202.26321019 10.1016/j.biopsych.2015.07.020
5. De Dreu CK The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans Science 2010 328 5984 1408 1411 10.1126/science.1189047 20538951
De Dreu CK, et al. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science. 2010;328(5984):1408–11.20538951 10.1126/science.1189047
6. Sheng F Oxytocin modulates the racial bias in neural responses to others' suffering Biol Psychol 2013 92 2 380 386 10.1016/j.biopsycho.2012.11.018 23246533
Sheng F, et al. Oxytocin modulates the racial bias in neural responses to others’ suffering. Biol Psychol. 2013;92(2):380–6.23246533 10.1016/j.biopsycho.2012.11.018
7. Borland JM Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis Neuropsychopharmacology 2019 44 1 97 110 10.1038/s41386-018-0129-2 29968846
Borland JM, et al. Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis. Neuropsychopharmacology. 2019;44(1):97–110.29968846 10.1038/s41386-018-0129-2
8. Sharma K Sexually dimorphic oxytocin receptor-expressing neurons in the preoptic area of the mouse brain PLoS ONE 2019 14 7 e0219784 10.1371/journal.pone.0219784 31295328
Sharma K, et al. Sexually dimorphic oxytocin receptor-expressing neurons in the preoptic area of the mouse brain. PLoS ONE. 2019;14(7):e0219784.31295328 10.1371/journal.pone.0219784
9. Grinevich V Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain Biol Psychiatry 2016 79 3 155 164 10.1016/j.biopsych.2015.04.013 26001309
Grinevich V, et al. Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain. Biol Psychiatry. 2016;79(3):155–64.26001309 10.1016/j.biopsych.2015.04.013
10. Inoue K Oxytocin receptors are widely distributed in the prairie vole (Microtus ochrogaster) brain: Relation to social behavior, genetic polymorphisms, and the dopamine system J Comp Neurol 2022 530 16 2881 2900 10.1002/cne.25382 35763609
Inoue K, et al. Oxytocin receptors are widely distributed in the prairie vole (Microtus ochrogaster) brain: Relation to social behavior, genetic polymorphisms, and the dopamine system. J Comp Neurol. 2022;530(16):2881–900.35763609 10.1002/cne.25382
11. Quintana DS Guastella AJ An Allostatic Theory of Oxytocin Trends Cogn Sci 2020 24 7 515 528 10.1016/j.tics.2020.03.008 32360118
Quintana DS, Guastella AJ. An Allostatic Theory of Oxytocin. Trends Cogn Sci. 2020;24(7):515–28.32360118 10.1016/j.tics.2020.03.008
12. Miura I Imaging the Neural Circuit Basis of Social Behavior: Insights from Mouse and Human Studies Neurol Med Chir (Tokyo) 2020 60 9 429 438 10.2176/nmc.ra.2020-0088 32863321
Miura I, et al. Imaging the Neural Circuit Basis of Social Behavior: Insights from Mouse and Human Studies. Neurol Med Chir (Tokyo). 2020;60(9):429–38.32863321 10.2176/nmc.ra.2020-0088
13••. Son S Whole-Brain Wiring Diagram of Oxytocin System in Adult Mice J Neurosci 2022 42 25 5021 5033 10.1523/JNEUROSCI.0307-22.2022 35606144
Son S, et al. Whole-Brain Wiring Diagram of Oxytocin System in Adult Mice. J Neurosci. 2022;42(25):5021–33.35606144 10.1523/JNEUROSCI.0307-22.2022
14. Liao PY Mapping Central Projection of Oxytocin Neurons in Unmated Mice Using Cre and Alkaline Phosphatase Reporter Front Neuroanat 2020 14 559402 10.3389/fnana.2020.559402 33192340
Liao PY, et al. Mapping Central Projection of Oxytocin Neurons in Unmated Mice Using Cre and Alkaline Phosphatase Reporter. Front Neuroanat. 2020;14:559402.33192340 10.3389/fnana.2020.559402
15. Rigney N Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities Endocrinology 2022 163 9 bqac111 10.1210/endocr/bqac111 35863332
Rigney N, et al. Oxytocin, Vasopressin, and Social Behavior: From Neural Circuits to Clinical Opportunities. Endocrinology. 2022;163(9):bqac111.35863332 10.1210/endocr/bqac111
16. Veening JG de Jong T Barendregt HP Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review Physiol Behav 2010 101 2 193 210 10.1016/j.physbeh.2010.05.004 20493198
Veening JG, de Jong T, Barendregt HP. Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review. Physiol Behav. 2010;101(2):193–210.20493198 10.1016/j.physbeh.2010.05.004
17. Zheng JJ Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices Nat Neurosci 2014 17 3 391 399 10.1038/nn.3634 24464043
Zheng JJ, et al. Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices. Nat Neurosci. 2014;17(3):391–9.24464043 10.1038/nn.3634
18. Song ZM Albers HE Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery Front Neuroendocrinol 2018 51 14 24 10.1016/j.yfrne.2017.10.004 29054552
Song ZM, Albers HE. Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery. Front Neuroendocrinol. 2018;51:14–24.29054552 10.1016/j.yfrne.2017.10.004
19. Nersesyan Y Oxytocin Modulates Nociception as an Agonist of Pain-Sensing TRPV1 Cell Rep 2017 21 6 1681 1691 10.1016/j.celrep.2017.10.063 29117570
Nersesyan Y, et al. Oxytocin Modulates Nociception as an Agonist of Pain-Sensing TRPV1. Cell Rep. 2017;21(6):1681–91.29117570 10.1016/j.celrep.2017.10.063
20. Grinevich V Neumann ID Brain oxytocin: how puzzle stones from animal studies translate into psychiatry Mol Psychiatry 2021 26 1 265 279 10.1038/s41380-020-0802-9 32514104
Grinevich V, Neumann ID. Brain oxytocin: how puzzle stones from animal studies translate into psychiatry. Mol Psychiatry. 2021;26(1):265–79.32514104 10.1038/s41380-020-0802-9
21. Hasan MT A Fear Memory Engram and Its Plasticity in the Hypothalamic Oxytocin System Neuron 2019 103 1 133 146 10.1016/j.neuron.2019.04.029 31104950
Hasan MT, et al. A Fear Memory Engram and Its Plasticity in the Hypothalamic Oxytocin System. Neuron. 2019;103(1):133–46.31104950 10.1016/j.neuron.2019.04.029
22. Zhang B Reconstruction of the Hypothalamo-Neurohypophysial System and Functional Dissection of Magnocellular Oxytocin Neurons in the Brain Neuron 2021 109 2 331 346 10.1016/j.neuron.2020.10.032 33212012
Zhang B, et al. Reconstruction of the Hypothalamo-Neurohypophysial System and Functional Dissection of Magnocellular Oxytocin Neurons in the Brain. Neuron. 2021;109(2):331–46.33212012 10.1016/j.neuron.2020.10.032
23. Taniguchi Y The distribution of vasopressin- or oxytocin-neurons projecting to the posterior pituitary as revealed by a combination of retrograde transport of horseradish peroxidase and immunohistochemistry Arch Histol Cytol 1988 51 1 83 89 10.1679/aohc.51.83 3137951
Taniguchi Y, et al. The distribution of vasopressin- or oxytocin-neurons projecting to the posterior pituitary as revealed by a combination of retrograde transport of horseradish peroxidase and immunohistochemistry. Arch Histol Cytol. 1988;51(1):83–9.3137951 10.1679/aohc.51.83
24. Soumier A Differential fate between oxytocin and vasopressin cells in the developing mouse brain iScience 2022 25 1 103655 10.1016/j.isci.2021.103655 35028535
Soumier A, et al. Differential fate between oxytocin and vasopressin cells in the developing mouse brain. iScience. 2022;25(1):103655.35028535 10.1016/j.isci.2021.103655
25. Kim Y Mapping social behavior-induced brain activation at cellular resolution in the mouse Cell Rep 2015 10 2 292 305 10.1016/j.celrep.2014.12.014 25558063
Kim Y, et al. Mapping social behavior-induced brain activation at cellular resolution in the mouse. Cell Rep. 2015;10(2):292–305.25558063 10.1016/j.celrep.2014.12.014
26. Choe KY Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse Neuron 2022 110 5 795 808 10.1016/j.neuron.2021.11.031 34932941
Choe KY, et al. Oxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse. Neuron. 2022;110(5):795–808.34932941 10.1016/j.neuron.2021.11.031
27•. Y, Tang, et al. Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. Nat Neurosci. 2020;23(9):1125–37.
28. Eliava M A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing Neuron 2016 89 6 1291 1304 10.1016/j.neuron.2016.01.041 26948889
Eliava M, et al. A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing. Neuron. 2016;89(6):1291–304.26948889 10.1016/j.neuron.2016.01.041
29. Resendez SL Social Stimuli Induce Activation of Oxytocin Neurons Within the Paraventricular Nucleus of the Hypothalamus to Promote Social Behavior in Male Mice J Neurosci 2020 40 11 2282 2295 10.1523/JNEUROSCI.1515-18.2020 32024781
Resendez SL, et al. Social Stimuli Induce Activation of Oxytocin Neurons Within the Paraventricular Nucleus of the Hypothalamus to Promote Social Behavior in Male Mice. J Neurosci. 2020;40(11):2282–95.32024781 10.1523/JNEUROSCI.1515-18.2020
30. Li Y Neuronal Representation of Social Information in the Medial Amygdala of Awake Behaving Mice Cell 2017 171 5 1176 1190 10.1016/j.cell.2017.10.015 29107332
Li Y, et al. Neuronal Representation of Social Information in the Medial Amygdala of Awake Behaving Mice. Cell. 2017;171(5):1176–90.29107332 10.1016/j.cell.2017.10.015
31. Zhang L Miniscope GRIN Lens System for Calcium Imaging of Neuronal Activity from Deep Brain Structures in Behaving Animals Curr Protoc Neurosci 2019 86 1 e56 10.1002/cpns.56 30315730
Zhang L, et al. Miniscope GRIN Lens System for Calcium Imaging of Neuronal Activity from Deep Brain Structures in Behaving Animals. Curr Protoc Neurosci. 2019;86(1):e56.30315730 10.1002/cpns.56
32. Qian TR A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments Nat Biotechnol 2023 41 7 944 10.1038/s41587-022-01561-2 36593404
Qian TR, et al. A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments. Nat Biotechnol. 2023;41(7):944.36593404 10.1038/s41587-022-01561-2
33. Iwasaki M An analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray in rats Nat Commun 2023 14 1 1066 10.1038/s41467-023-36641-7 36828816
Iwasaki M, et al. An analgesic pathway from parvocellular oxytocin neurons to the periaqueductal gray in rats. Nat Commun. 2023;14(1):1066.36828816 10.1038/s41467-023-36641-7
34. Lee J Raycraft L Johnson AW The dynamic regulation of appetitive behavior through lateral hypothalamic orexin and melanin concentrating hormone expressing cells Physiol Behav 2021 229 113234 10.1016/j.physbeh.2020.113234 33130035
Lee J, Raycraft L, Johnson AW. The dynamic regulation of appetitive behavior through lateral hypothalamic orexin and melanin concentrating hormone expressing cells. Physiol Behav. 2021;229:113234.33130035 10.1016/j.physbeh.2020.113234
35. Gonzalez MI Vaziri S Wilson CA Behavioral effects of alpha-MSH and MCH after central administration in the female rat Peptides 1996 17 1 171 177 10.1016/0196-9781(95)02092-6 8822527
Gonzalez MI, Vaziri S, Wilson CA. Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides. 1996;17(1):171–7.8822527 10.1016/0196-9781(95)02092-6
36. Blouin AM Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction Nat Commun 2013 4 1547 10.1038/ncomms2461 23462990
Blouin AM, et al. Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun. 2013;4:1547.23462990 10.1038/ncomms2461
37. Alachkar A Inactivation of the melanin concentrating hormone system impairs maternal behavior Eur Neuropsychopharmacol 2016 26 11 1826 1835 10.1016/j.euroneuro.2016.08.014 27617778
Alachkar A, et al. Inactivation of the melanin concentrating hormone system impairs maternal behavior. Eur Neuropsychopharmacol. 2016;26(11):1826–35.27617778 10.1016/j.euroneuro.2016.08.014
38. Alhassen L The role of Olfaction in MCH-regulated spontaneous maternal responses Brain Res 2019 1719 71 76 10.1016/j.brainres.2019.05.021 31121161
Alhassen L, et al. The role of Olfaction in MCH-regulated spontaneous maternal responses. Brain Res. 2019;1719:71–6.31121161 10.1016/j.brainres.2019.05.021
39. Sanathara NM Melanin concentrating hormone modulates oxytocin-mediated marble burying Neuropharmacology 2018 128 22 32 10.1016/j.neuropharm.2017.09.008 28888943
Sanathara NM, et al. Melanin concentrating hormone modulates oxytocin-mediated marble burying. Neuropharmacology. 2018;128:22–32.28888943 10.1016/j.neuropharm.2017.09.008
40. Yao Y Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons Am J Physiol Regul Integr Comp Physiol 2012 302 7 R815 R824 10.1152/ajpregu.00452.2011 22262306
Yao Y, et al. Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons. Am J Physiol Regul Integr Comp Physiol. 2012;302(7):R815–24.22262306 10.1152/ajpregu.00452.2011
41. Sanathara N Oxytocin-MCH circuit regulates monosynaptic inputs to MCH neurons and modulates social recognition memory Neuropharmacology 2021 184 108423 10.1016/j.neuropharm.2020.108423 33290754
Sanathara N, et al. Oxytocin-MCH circuit regulates monosynaptic inputs to MCH neurons and modulates social recognition memory. Neuropharmacology. 2021;184:108423.33290754 10.1016/j.neuropharm.2020.108423
42. Phan J Mating and parenting experiences sculpture mood-modulating effects of oxytocin-MCH signaling Sci Rep 2020 10 1 13611 10.1038/s41598-020-70667-x 32788646
Phan J, et al. Mating and parenting experiences sculpture mood-modulating effects of oxytocin-MCH signaling. Sci Rep. 2020;10(1):13611.32788646 10.1038/s41598-020-70667-x
43. Nasanbuyan N Oxytocin-Oxytocin Receptor Systems Facilitate Social Defeat Posture in Male Mice Endocrinology 2018 159 2 763 775 10.1210/en.2017-00606 29186377
Nasanbuyan N, et al. Oxytocin-Oxytocin Receptor Systems Facilitate Social Defeat Posture in Male Mice. Endocrinology. 2018;159(2):763–75.29186377 10.1210/en.2017-00606
44. Yoshida M Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice J Neurosci 2009 29 7 2259 2271 10.1523/JNEUROSCI.5593-08.2009 19228979
Yoshida M, et al. Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice. J Neurosci. 2009;29(7):2259–71.19228979 10.1523/JNEUROSCI.5593-08.2009
45. Lefevre A Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate J Neurosci 2017 37 28 6741 6750 10.1523/JNEUROSCI.0659-17.2017 28607170
Lefevre A, et al. Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate. J Neurosci. 2017;37(28):6741–50.28607170 10.1523/JNEUROSCI.0659-17.2017
46. Mottolese R Switching brain serotonin with oxytocin Proc Natl Acad Sci U S A 2014 111 23 8637 8642 10.1073/pnas.1319810111 24912179
Mottolese R, et al. Switching brain serotonin with oxytocin. Proc Natl Acad Sci U S A. 2014;111(23):8637–42.24912179 10.1073/pnas.1319810111
47. Dolen G Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin Nature 2013 501 7466 179 184 10.1038/nature12518 24025838
Dolen G, et al. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature. 2013;501(7466):179–84.24025838 10.1038/nature12518
48•. Liu Y Molecular and cellular mechanisms of the first social relationship: A conserved role of 5-HT from mice to monkeys, upstream of oxytocin Neuron 2023 111 9 1468 1485 10.1016/j.neuron.2023.02.010 36868221
Liu Y, et al. Molecular and cellular mechanisms of the first social relationship: A conserved role of 5-HT from mice to monkeys, upstream of oxytocin. Neuron. 2023;111(9):1468–85.36868221 10.1016/j.neuron.2023.02.010
49. Salehi MS Co-Stimulation of Oxytocin and Arginine-Vasopressin Receptors Affect Hypothalamic Neurospheroid Size Int J Mol Sci 2021 22 16 8464 10.3390/ijms22168464 34445168
Salehi MS, et al. Co-Stimulation of Oxytocin and Arginine-Vasopressin Receptors Affect Hypothalamic Neurospheroid Size. Int J Mol Sci. 2021;22(16):8464.34445168 10.3390/ijms22168464
50. Hicks C Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats Br J Pharmacol 2014 171 11 2868 2887 10.1111/bph.12613 24641248
Hicks C, et al. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br J Pharmacol. 2014;171(11):2868–87.24641248 10.1111/bph.12613
51. Taylor JH Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains J Neuroendocrinol 2020 32 7 e12882 10.1111/jne.12882 32662552
Taylor JH, et al. Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains. J Neuroendocrinol. 2020;32(7):e12882.32662552 10.1111/jne.12882
52. Mustoe A Leu(8) and Pro(8) oxytocin agonism differs across human, macaque, and marmoset vasopressin 1a receptors Sci Rep 2019 9 1 15480 10.1038/s41598-019-52024-9 31664130
Mustoe A, et al. Leu(8) and Pro(8) oxytocin agonism differs across human, macaque, and marmoset vasopressin 1a receptors. Sci Rep. 2019;9(1):15480.31664130 10.1038/s41598-019-52024-9
53. Pierce ML French JA Murray TF Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor Biomed Pharmacother 2020 126 110060 10.1016/j.biopha.2020.110060 32145592
Pierce ML, French JA, Murray TF. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor. Biomed Pharmacother. 2020;126:110060.32145592 10.1016/j.biopha.2020.110060
54. Smith CJW DiBenedictis BT Veenema AH Comparing vasopressin and oxytocin fiber and receptor density patterns in the social behavior neural network: Implications for cross-system signaling Front Neuroendocrinol 2019 53 100737 10.1016/j.yfrne.2019.02.001 30753840
Smith CJW, DiBenedictis BT, Veenema AH. Comparing vasopressin and oxytocin fiber and receptor density patterns in the social behavior neural network: Implications for cross-system signaling. Front Neuroendocrinol. 2019;53:100737.30753840 10.1016/j.yfrne.2019.02.001
55. Uvnas-Moberg K Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocin BMC Pregnancy Childbirth 2019 19 1 285 10.1186/s12884-019-2365-9 31399062
Uvnas-Moberg K, et al. Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocin. BMC Pregnancy Childbirth. 2019;19(1):285.31399062 10.1186/s12884-019-2365-9
56. Temesi A Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs Front Vet Sci 2017 4 147 10.3389/fvets.2017.00147 28929104
Temesi A, et al. Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs. Front Vet Sci. 2017;4:147.28929104 10.3389/fvets.2017.00147
57. Lee MR Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques Nat Commun 2020 11 1 2783 10.1038/s41467-020-15942-1 32494001
Lee MR, et al. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nat Commun. 2020;11(1):2783.32494001 10.1038/s41467-020-15942-1
58. Tabak BA Advances in human oxytocin measurement: challenges and proposed solutions Mol Psychiatry 2023 28 1 127 140 10.1038/s41380-022-01719-z 35999276
Tabak BA, et al. Advances in human oxytocin measurement: challenges and proposed solutions. Mol Psychiatry. 2023;28(1):127–40.35999276 10.1038/s41380-022-01719-z
59. Maynard KR BDNF-TrkB signaling in oxytocin neurons contributes to maternal behavior Elife 2018 7 e33676 10.7554/eLife.33676 30192229
Maynard KR, et al. BDNF-TrkB signaling in oxytocin neurons contributes to maternal behavior. Elife. 2018;7:e33676.30192229 10.7554/eLife.33676
60. Carcea I Oxytocin neurons enable social transmission of maternal behaviour Nature 2021 596 7873 553 557 10.1038/s41586-021-03814-7 34381215
Carcea I, et al. Oxytocin neurons enable social transmission of maternal behaviour. Nature. 2021;596(7873):553–7.34381215 10.1038/s41586-021-03814-7
61. Marlin BJ Oxytocin enables maternal behaviour by balancing cortical inhibition Nature 2015 520 7548 499 504 10.1038/nature14402 25874674
Marlin BJ, et al. Oxytocin enables maternal behaviour by balancing cortical inhibition. Nature. 2015;520(7548):499–504.25874674 10.1038/nature14402
62. Valtcheva S Neural circuitry for maternal oxytocin release induced by infant cries Nature 2023 621 7980 788 795 10.1038/s41586-023-06540-4 37730989
Valtcheva S, et al. Neural circuitry for maternal oxytocin release induced by infant cries. Nature. 2023;621(7980):788–95.37730989 10.1038/s41586-023-06540-4
63. Harlow HF Maternal Behavior of Rhesus Monkeys Deprived of Mothering and Peer Associations in Infancy Proc Am Philos Soc 1966 110 1 58 66
Harlow HF, et al. Maternal Behavior of Rhesus Monkeys Deprived of Mothering and Peer Associations in Infancy. Proc Am Philos Soc. 1966;110(1):58–66.
64. Harlow HR Dodsworth and M Harlow, Total social isolation of monkeys. National Academy of Sciences of the United States of America, 1965
65. Bales KL Social touch during development: Long-term effects on brain and behavior Neurosci Biobehav Rev 2018 95 202 219 10.1016/j.neubiorev.2018.09.019 30278194
Bales KL, et al. Social touch during development: Long-term effects on brain and behavior. Neurosci Biobehav Rev. 2018;95:202–19.30278194 10.1016/j.neubiorev.2018.09.019
66••. Yu H Social touch-like tactile stimulation activates a tachykinin 1-oxytocin pathway to promote social interactions Neuron 2022 110 6 1051 1067 10.1016/j.neuron.2021.12.022 35045339
Yu H, et al. Social touch-like tactile stimulation activates a tachykinin 1-oxytocin pathway to promote social interactions. Neuron. 2022;110(6):1051–67.35045339 10.1016/j.neuron.2021.12.022
67. Argiolas A Melis MR Gessa GL Oxytocin: an extremely potent inducer of penile erection and yawning in male rats Eur J Pharmachol 1986 1 130 265 272 10.1016/0014-2999(86)90277-3
Argiolas A, Melis MR, Gessa GL. Oxytocin: an extremely potent inducer of penile erection and yawning in male rats. Eur J Pharmachol. 1986;1(130):265–72.10.1016/0014-2999(86)90277-3
68. Melis MR Argiolas A Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances Int J Mol Sci 2021 22 19 10376 10.3390/ijms221910376 34638719
Melis MR, Argiolas A. Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances. Int J Mol Sci. 2021;22(19):10376.34638719 10.3390/ijms221910376
69•. Wen YX Oxytocinergic neurons, but not oxytocin, are crucial for male penile erection Neuropharmacology 2023 235 109576 10.1016/j.neuropharm.2023.109576 37164226
Wen YX, et al. Oxytocinergic neurons, but not oxytocin, are crucial for male penile erection. Neuropharmacology. 2023;235:109576.37164226 10.1016/j.neuropharm.2023.109576
70. Bratzu J Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study Behavi Brain Res 2019 375 112147 10.1016/j.bbr.2019.112147
Bratzu J, et al. Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study. Behavi Brain Res. 2019;375:112147.10.1016/j.bbr.2019.112147
71. Bratzu J Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study Behav Brain Res 2019 375 112147 10.1016/j.bbr.2019.112147 31408664
Bratzu J, et al. Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study. Behav Brain Res. 2019;375:112147.31408664 10.1016/j.bbr.2019.112147
72. Masugi-Tokita M Metabotropic Glutamate Receptor Subtype 7 Is Essential for Ejaculation Mol Neurobiol 2020 57 12 5208 5218 10.1007/s12035-020-02090-2 32865662
Masugi-Tokita M, et al. Metabotropic Glutamate Receptor Subtype 7 Is Essential for Ejaculation. Mol Neurobiol. 2020;57(12):5208–18.32865662 10.1007/s12035-020-02090-2
73. Chen G Dopamine D2 receptors in the nucleus accumbens modulate erectile function in a rat model of nonorganic erectile dysfunction Andrology 2022 10 4 808 817 10.1111/andr.13171 35235251
Chen G, et al. Dopamine D2 receptors in the nucleus accumbens modulate erectile function in a rat model of nonorganic erectile dysfunction. Andrology. 2022;10(4):808–17.35235251 10.1111/andr.13171
74. Dhungel S Oxytocin is indispensable for conspecific-odor preference and controls the initiation of female, but not male, sexual behavior in mice Neurosci Res 2019 148 34 41 10.1016/j.neures.2018.11.008 30502354
Dhungel S, et al. Oxytocin is indispensable for conspecific-odor preference and controls the initiation of female, but not male, sexual behavior in mice. Neurosci Res. 2019;148:34–41.30502354 10.1016/j.neures.2018.11.008
75. Pierzynowska K Roles of the Oxytocin Receptor (OXTR) in Human Diseases Int J Mol Sci 2023 24 4 3887 10.3390/ijms24043887 36835321
Pierzynowska K, et al. Roles of the Oxytocin Receptor (OXTR) in Human Diseases. Int J Mol Sci. 2023;24(4):3887.36835321 10.3390/ijms24043887
76. Coskuner ER Ozkan B Premature Ejaculation and Endocrine Disorders: A Literature Review World J Mens Health 2022 40 1 38 51 10.5534/wjmh.200184 33831976
Coskuner ER, Ozkan B. Premature Ejaculation and Endocrine Disorders: A Literature Review. World J Mens Health. 2022;40(1):38–51.33831976 10.5534/wjmh.200184
77. Filippi S Role of oxytocin in the ejaculatory process J Endocrinol Invest 2003 26 3 Suppl 82 86 12834028
Filippi S, et al. Role of oxytocin in the ejaculatory process. J Endocrinol Invest. 2003;26(3 Suppl):82–6.12834028
78. Stadler B Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists Front Endocrinol (Lausanne) 2020 11 565731 10.3389/fendo.2020.565731 33193084
Stadler B, et al. Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists. Front Endocrinol (Lausanne). 2020;11:565731.33193084 10.3389/fendo.2020.565731
79. Oti T Sakamoto T Sakamoto H Systemic effects of oxytocin on male sexual activity via the spinal ejaculation generator in rats Commun Integr Biol 2021 14 1 55 60 10.1080/19420889.2021.1902056 33828638
Oti T, Sakamoto T, Sakamoto H. Systemic effects of oxytocin on male sexual activity via the spinal ejaculation generator in rats. Commun Integr Biol. 2021;14(1):55–60.33828638 10.1080/19420889.2021.1902056
80. Semple EA Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice Front Endocrinol (Lausanne) 2023 14 983670 10.3389/fendo.2023.983670 37033219
Semple EA, et al. Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice. Front Endocrinol (Lausanne). 2023;14:983670.37033219 10.3389/fendo.2023.983670
81. Paiva L, et al. Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats. J Neuroendocrinol. 2017;29(2).
82. Penagarikano, O., et al., Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med, 2015. 7 271 271ra8
83. Semple E Hill JW Sim1 Neurons Are Sufficient for MC4R-Mediated Sexual Function in Male Mice Endocrinology 2018 159 1 439 449 10.1210/en.2017-00488 29059347
Semple E, Hill JW. Sim1 Neurons Are Sufficient for MC4R-Mediated Sexual Function in Male Mice. Endocrinology. 2018;159(1):439–49.29059347 10.1210/en.2017-00488
84. Argiolas A Erectile Dysfunction: Treatments, Advances and New Therapeutic Strategies Brain Sci 2023 13 5 802 10.3390/brainsci13050802 37239274
Argiolas A, et al. Erectile Dysfunction: Treatments, Advances and New Therapeutic Strategies. Brain Sci. 2023;13(5):802.37239274 10.3390/brainsci13050802
85. Flanagan LM Induction of FOS immunoreactivity in oxytocin neurons after sexual activity in female rats Neuroendocrinology 1993 58 3 352 358 10.1159/000126562 8255396
Flanagan LM, et al. Induction of FOS immunoreactivity in oxytocin neurons after sexual activity in female rats. Neuroendocrinology. 1993;58(3):352–8.8255396 10.1159/000126562
86. Nyuyki KD Yes, I am ready now: differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats PLoS ONE 2011 6 8 e23599 10.1371/journal.pone.0023599 21858181
Nyuyki KD, et al. Yes, I am ready now: differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats. PLoS ONE. 2011;6(8):e23599.21858181 10.1371/journal.pone.0023599
87. Caldwell JD Medial preoptic area oxytocin and female sexual receptivity Behav Neurosci 1989 103 3 655 662 10.1037/0735-7044.103.3.655 2660848
Caldwell JD, et al. Medial preoptic area oxytocin and female sexual receptivity. Behav Neurosci. 1989;103(3):655–62.2660848 10.1037/0735-7044.103.3.655
88. Schulze HG Gorzalka BB Oxytocin effects on lordosis frequency and lordosis duration following infusion into the medial pre-optic area and ventromedial hypothalamus of female rats Neuropeptides 1991 18 2 99 106 10.1016/0143-4179(91)90008-7 2017303
Schulze HG, Gorzalka BB. Oxytocin effects on lordosis frequency and lordosis duration following infusion into the medial pre-optic area and ventromedial hypothalamus of female rats. Neuropeptides. 1991;18(2):99–106.2017303 10.1016/0143-4179(91)90008-7
89. Becker RO Sexual behavior and dendritic spine density of posterodorsal medial amygdala neurons in oxytocin knockout female mice Behav Brain Res 2013 256 95 100 10.1016/j.bbr.2013.07.034 23906766
Becker RO, et al. Sexual behavior and dendritic spine density of posterodorsal medial amygdala neurons in oxytocin knockout female mice. Behav Brain Res. 2013;256:95–100.23906766 10.1016/j.bbr.2013.07.034
90. Nishikawa Y Hepatocytic cells form bile duct-like structures within a three-dimensional collagen gel matrix Exp Cell Res 1996 223 2 357 371 10.1006/excr.1996.0091 8601413
Nishikawa Y, et al. Hepatocytic cells form bile duct-like structures within a three-dimensional collagen gel matrix. Exp Cell Res. 1996;223(2):357–71.8601413 10.1006/excr.1996.0091
91. Cushing BS Carter CS Prior exposure To oxytocin mimics the effects Of social contact and facilitates sexual behaviour In females J Neuroendocrinol 1999 11 10 765 769 10.1046/j.1365-2826.1999.00382.x 10520125
Cushing BS, Carter CS. Prior exposure To oxytocin mimics the effects Of social contact and facilitates sexual behaviour In females. J Neuroendocrinol. 1999;11(10):765–9.10520125 10.1046/j.1365-2826.1999.00382.x
92. Carter CS Oxytocin and Sexual-Behavior Neurosci Biobehav Rev 1992 16 2 131 144 10.1016/S0149-7634(05)80176-9 1630727
Carter CS. Oxytocin and Sexual-Behavior. Neurosci Biobehav Rev. 1992;16(2):131–44.1630727 10.1016/S0149-7634(05)80176-9
93. Carmichael MS Relationships among cardiovascular, muscular, and oxytocin responses during human sexual activity Arch Sex Behav 1994 23 1 59 79 10.1007/BF01541618 8135652
Carmichael MS, et al. Relationships among cardiovascular, muscular, and oxytocin responses during human sexual activity. Arch Sex Behav. 1994;23(1):59–79.8135652 10.1007/BF01541618
94. Kruger THC Effects of Intranasal Oxytocin Administration on Sexual Functions in Healthy Women: A Laboratory Paradigm J Clin Psychopharmacol 2018 38 3 239 242 10.1097/JCP.0000000000000863 29596150
Kruger THC, et al. Effects of Intranasal Oxytocin Administration on Sexual Functions in Healthy Women: A Laboratory Paradigm. J Clin Psychopharmacol. 2018;38(3):239–42.29596150 10.1097/JCP.0000000000000863
95. Behnia B Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples Horm Behav 2014 65 3 308 318 10.1016/j.yhbeh.2014.01.009 24503174
Behnia B, et al. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav. 2014;65(3):308–18.24503174 10.1016/j.yhbeh.2014.01.009
96. Borie AM Social experience alters oxytocinergic modulation in the nucleus accumbens of female prairie voles Curr Biol 2022 32 5 1026 1037 10.1016/j.cub.2022.01.014 35108521
Borie AM, et al. Social experience alters oxytocinergic modulation in the nucleus accumbens of female prairie voles. Curr Biol. 2022;32(5):1026–37.35108521 10.1016/j.cub.2022.01.014
97. Schneiderman I Oxytocin during the initial stages of romantic attachment: relations to couples' interactive reciprocity Psychoneuroendocrinology 2012 37 8 1277 1285 10.1016/j.psyneuen.2011.12.021 22281209
Schneiderman I, et al. Oxytocin during the initial stages of romantic attachment: relations to couples’ interactive reciprocity. Psychoneuroendocrinology. 2012;37(8):1277–85.22281209 10.1016/j.psyneuen.2011.12.021
98. Algoe SB Kurtz LE Grewen K Oxytocin and Social Bonds: The Role of Oxytocin in Perceptions of Romantic Partners' Bonding Behavior Psychol Sci 2017 28 12 1763 1772 10.1177/0956797617716922 28968183
Algoe SB, Kurtz LE, Grewen K. Oxytocin and Social Bonds: The Role of Oxytocin in Perceptions of Romantic Partners’ Bonding Behavior. Psychol Sci. 2017;28(12):1763–72.28968183 10.1177/0956797617716922
99. Feifel D Shilling PD MacDonald K A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia Biol Psychiatry 2016 79 3 222 233 10.1016/j.biopsych.2015.07.025 26410353
Feifel D, Shilling PD, MacDonald K. A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia. Biol Psychiatry. 2016;79(3):222–33.26410353 10.1016/j.biopsych.2015.07.025
100. Andari E Hurlemann R Young LJ A Precision Medicine Approach to Oxytocin Trials Curr Top Behav Neurosci 2018 35 559 590 10.1007/7854_2017_29 28812273
Andari E, Hurlemann R, Young LJ. A Precision Medicine Approach to Oxytocin Trials. Curr Top Behav Neurosci. 2018;35:559–90.28812273 10.1007/7854_2017_29
101. Meyer-Lindenberg A Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine Nat Rev Neurosci 2011 12 9 524 538 10.1038/nrn3044 21852800
Meyer-Lindenberg A, et al. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12(9):524–38.21852800 10.1038/nrn3044
102. Guastella AJ Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders Biol Psychiatry 2010 67 7 692 694 10.1016/j.biopsych.2009.09.020 19897177
Guastella AJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010;67(7):692–4.19897177 10.1016/j.biopsych.2009.09.020
103. Andari E Promoting social behavior with oxytocin in high-functioning autism spectrum disorders Proc Natl Acad Sci U S A 2010 107 9 4389 4394 10.1073/pnas.0910249107 20160081
Andari E, et al. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A. 2010;107(9):4389–94.20160081 10.1073/pnas.0910249107
104. Sikich L Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder N Engl J Med 2021 385 16 1462 1473 10.1056/NEJMoa2103583 34644471
Sikich L, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 2021;385(16):1462–73.34644471 10.1056/NEJMoa2103583
105. Straccia MA Null results of oxytocin and vasopressin administration on mentalizing in a large fMRI sample: evidence from a randomized controlled trial Psychol Med 2023 53 6 2285 2295 10.1017/S0033291721004104 37310308
Straccia MA, et al. Null results of oxytocin and vasopressin administration on mentalizing in a large fMRI sample: evidence from a randomized controlled trial. Psychol Med. 2023;53(6):2285–95.37310308 10.1017/S0033291721004104
106. Tabak BA Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial Psychoneuroendocrinology 2019 107 124 132 10.1016/j.psyneuen.2019.04.019 31128568
Tabak BA, et al. Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial. Psychoneuroendocrinology. 2019;107:124–32.31128568 10.1016/j.psyneuen.2019.04.019
107. Dwyer, K.R., et al., 2020 A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social Affiliation. Schizophr Bull Open 1(1) sgaa001
108. Yamasue H Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial Mol Psychiatry 2020 25 8 1849 1858 10.1038/s41380-018-0097-2 29955161
Yamasue H, et al. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial. Mol Psychiatry. 2020;25(8):1849–58.29955161 10.1038/s41380-018-0097-2
109. Watanabe T Mitigation of Sociocommunicational Deficits of Autism Through Oxytocin-Induced Recovery of Medial Prefrontal Activity A Randomized Trial JAMA Psychiat 2014 71 2 166 175 10.1001/jamapsychiatry.2013.3181
Watanabe T, et al. Mitigation of Sociocommunicational Deficits of Autism Through Oxytocin-Induced Recovery of Medial Prefrontal Activity A Randomized Trial. JAMA Psychiat. 2014;71(2):166–75.10.1001/jamapsychiatry.2013.3181
110. Ford CL Young LJ Refining oxytocin therapy for autism: context is key Nat Rev Neurol 2022 18 2 67 68 10.1038/s41582-021-00602-9 34880473
Ford CL, Young LJ. Refining oxytocin therapy for autism: context is key. Nat Rev Neurol. 2022;18(2):67–8.34880473 10.1038/s41582-021-00602-9
111. Le J Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial Psychother Psychosom 2022 91 5 335 347 10.1159/000524543 35545057
Le J, et al. Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial. Psychother Psychosom. 2022;91(5):335–47.35545057 10.1159/000524543
112. Moerkerke M Chronic oxytocin administration stimulates the oxytocinergic system in children with autism Nat Commun 2024 15 1 58 10.1038/s41467-023-44334-4 38167302
Moerkerke M, et al. Chronic oxytocin administration stimulates the oxytocinergic system in children with autism. Nat Commun. 2024;15(1):58.38167302 10.1038/s41467-023-44334-4
113. Leng G Ludwig M Intranasal Oxytocin: Myths and Delusions Biol Psychiatry 2016 79 3 243 250 10.1016/j.biopsych.2015.05.003 26049207
Leng G, Ludwig M. Intranasal Oxytocin: Myths and Delusions. Biol Psychiatry. 2016;79(3):243–50.26049207 10.1016/j.biopsych.2015.05.003
114. Smith AS Korgan AC Young WS Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice Pharmacol Res 2019 146 104324 10.1016/j.phrs.2019.104324 31238093
Smith AS, Korgan AC, Young WS. Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice. Pharmacol Res. 2019;146:104324.31238093 10.1016/j.phrs.2019.104324
115. Neumann ID Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice Psychoneuroendocrinology 2013 38 10 1985 1993 10.1016/j.psyneuen.2013.03.003 23579082
Neumann ID, et al. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology. 2013;38(10):1985–93.23579082 10.1016/j.psyneuen.2013.03.003
116. Thorne RG Delivery of interferon-beta to the monkey nervous system following intranasal administration Neuroscience 2008 152 3 785 797 10.1016/j.neuroscience.2008.01.013 18304744
Thorne RG, et al. Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience. 2008;152(3):785–97.18304744 10.1016/j.neuroscience.2008.01.013
117. Lochhead JJ Thorne RG Intranasal delivery of biologics to the central nervous system Adv Drug Deliv Rev 2012 64 7 614 628 10.1016/j.addr.2011.11.002 22119441
Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614–28.22119441 10.1016/j.addr.2011.11.002
118. Yeomans DC Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations Transl Psychiatry 2021 11 1 388 10.1038/s41398-021-01511-7 34247185
Yeomans DC, et al. Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations. Transl Psychiatry. 2021;11(1):388.34247185 10.1038/s41398-021-01511-7
119. Jurek B Neumann ID The Oxytocin Receptor: From Intracellular Signaling to Behavior Physiol Rev 2018 98 3 1805 1908 10.1152/physrev.00031.2017 29897293
Jurek B, Neumann ID. The Oxytocin Receptor: From Intracellular Signaling to Behavior. Physiol Rev. 2018;98(3):1805–908.29897293 10.1152/physrev.00031.2017
120. Striepens N Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans Sci Rep 2013 3 3440 10.1038/srep03440 24310737
Striepens N, et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep. 2013;3:3440.24310737 10.1038/srep03440
121. Quintana DS Towards better hypothesis tests in oxytocin research: Evaluating the validity of auxiliary assumptions Psychoneuroendocrinology 2022 137 105642 10.1016/j.psyneuen.2021.105642 34991063
Quintana DS. Towards better hypothesis tests in oxytocin research: Evaluating the validity of auxiliary assumptions. Psychoneuroendocrinology. 2022;137:105642.34991063 10.1016/j.psyneuen.2021.105642
122. Goh KK Chen CH Lane HY Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment Int J Mol Sci 2021 22 4 2146 10.3390/ijms22042146 33670047
Goh KK, Chen CH, Lane HY. Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment. Int J Mol Sci. 2021;22(4):2146.33670047 10.3390/ijms22042146
123. Mitchell JM MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Nat Med 2021 27 6 1025 1033 10.1038/s41591-021-01336-3 33972795
Mitchell JM, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025–33.33972795 10.1038/s41591-021-01336-3
124. Yamamoto Y Higashida H RAGE regulates oxytocin transport into the brain Commun Biol 2020 3 1 70 10.1038/s42003-020-0799-2 32054984
Yamamoto Y, Higashida H. RAGE regulates oxytocin transport into the brain. Commun Biol. 2020;3(1):70.32054984 10.1038/s42003-020-0799-2
125. Kou J In the nose or on the tongue? Contrasting motivational effects of oral and intranasal oxytocin on arousal and reward during social processing Transl Psychiatry 2021 11 1 94 10.1038/s41398-021-01241-w 33542175
Kou J, et al. In the nose or on the tongue? Contrasting motivational effects of oral and intranasal oxytocin on arousal and reward during social processing. Transl Psychiatry. 2021;11(1):94.33542175 10.1038/s41398-021-01241-w
126. Hollander E Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders Neuropsychopharmacology 2003 28 1 193 198 10.1038/sj.npp.1300021 12496956
Hollander E, et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology. 2003;28(1):193–8.12496956 10.1038/sj.npp.1300021
127. Hollander E Oxytocin increases retention of social cognition in autism Biol Psychiatry 2007 61 4 498 503 10.1016/j.biopsych.2006.05.030 16904652
Hollander E, et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry. 2007;61(4):498–503.16904652 10.1016/j.biopsych.2006.05.030
128. Altszuler N Hampshire J Intranasal instillation of oxytocin increases insulin and glucagon secretion Proc Soc Exp Biol Med 1981 168 1 123 124 10.3181/00379727-168-41245 7033964
Altszuler N, Hampshire J. Intranasal instillation of oxytocin increases insulin and glucagon secretion. Proc Soc Exp Biol Med. 1981;168(1):123–4.7033964 10.3181/00379727-168-41245
129. Welch MG Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice Am J Physiol Gastrointest Liver Physiol 2014 307 8 G848 G862 10.1152/ajpgi.00176.2014 25147234
Welch MG, et al. Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. Am J Physiol Gastrointest Liver Physiol. 2014;307(8):G848–62.25147234 10.1152/ajpgi.00176.2014
130. Iwasaki Y Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity Am J Physiol Regul Integr Comp Physiol 2015 308 5 R360 R369 10.1152/ajpregu.00344.2014 25540101
Iwasaki Y, et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015;308(5):R360–9.25540101 10.1152/ajpregu.00344.2014
131. Kemp AH Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement PLoS ONE 2012 7 8 e44014 10.1371/journal.pone.0044014 22937145
Kemp AH, et al. Oxytocin increases heart rate variability in humans at rest: implications for social approach-related motivation and capacity for social engagement. PLoS ONE. 2012;7(8):e44014.22937145 10.1371/journal.pone.0044014
132. Tang Y Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons Nat Neurosci 2020 23 9 1125 1137 10.1038/s41593-020-0674-y 32719563
Tang Y, et al. Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. Nat Neurosci. 2020;23(9):1125–37.32719563 10.1038/s41593-020-0674-y
133. Cascio CJ Moore D McGlone F Social touch and human development Dev Cogn Neurosci 2019 35 5 11 10.1016/j.dcn.2018.04.009 29731417
Cascio CJ, Moore D, McGlone F. Social touch and human development. Dev Cogn Neurosci. 2019;35:5–11.29731417 10.1016/j.dcn.2018.04.009
134. MacDonald E A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research Psychoneuroendocrinology 2011 36 8 1114 1126 10.1016/j.psyneuen.2011.02.015 21429671
MacDonald E, et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011;36(8):1114–26.21429671 10.1016/j.psyneuen.2011.02.015
135. Verhees M No side-effects of single intranasal oxytocin administration in middle childhood Psychopharmacology 2018 235 8 2471 2477 10.1007/s00213-018-4945-1 29915962
Verhees M, et al. No side-effects of single intranasal oxytocin administration in middle childhood. Psychopharmacology. 2018;235(8):2471–7.29915962 10.1007/s00213-018-4945-1
136. Bales KL Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles Biol Psychiatry 2013 74 3 180 188 10.1016/j.biopsych.2012.08.025 23079235
Bales KL, et al. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol Psychiatry. 2013;74(3):180–8.23079235 10.1016/j.biopsych.2012.08.025
137. Peters S Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice Psychoneuroendocrinology 2014 42 225 236 10.1016/j.psyneuen.2014.01.021 24636519
Peters S, et al. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology. 2014;42:225–36.24636519 10.1016/j.psyneuen.2014.01.021
138. Huang H Chronic and acute intranasal oxytocin produce divergent social effects in mice Neuropsychopharmacology 2014 39 5 1102 1114 10.1038/npp.2013.310 24190025
Huang H, et al. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology. 2014;39(5):1102–14.24190025 10.1038/npp.2013.310
139. Horta M Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review Neurosci Biobehav Rev 2020 108 1 23 10.1016/j.neubiorev.2019.10.012 31647964
Horta M, et al. Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review. Neurosci Biobehav Rev. 2020;108:1–23.31647964 10.1016/j.neubiorev.2019.10.012
140. Norman GJ Oxytocin increases autonomic cardiac control: moderation by loneliness Biol Psychol 2011 86 3 174 180 10.1016/j.biopsycho.2010.11.006 21126557
Norman GJ, et al. Oxytocin increases autonomic cardiac control: moderation by loneliness. Biol Psychol. 2011;86(3):174–80.21126557 10.1016/j.biopsycho.2010.11.006
141. Rasmussen MS Effects of oxytocin in normal man during low and high sodium diets Acta Physiol Scand 2004 181 2 247 257 10.1111/j.1365-201X.2004.01286.x 15180798
Rasmussen MS, et al. Effects of oxytocin in normal man during low and high sodium diets. Acta Physiol Scand. 2004;181(2):247–57.15180798 10.1111/j.1365-201X.2004.01286.x
142. Leng G Leng RI Ludwig M Oxytocin-a social peptide? Deconstructing the evidence Philos Trans R Soc Lond B Biol Sci 1858 2022 377 20210055
Leng G, Leng RI, Ludwig M. Oxytocin-a social peptide? Deconstructing the evidence Philos Trans R Soc Lond B Biol Sci. 1858;2022(377):20210055.
143. Walum H Waldman ID Young LJ Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies Biol Psychiatry 2016 79 3 251 257 10.1016/j.biopsych.2015.06.016 26210057
Walum H, Waldman ID, Young LJ. Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies. Biol Psychiatry. 2016;79(3):251–7.26210057 10.1016/j.biopsych.2015.06.016
144. Winterton A Improving the precision of intranasal oxytocin research Nat Hum Behav 2021 5 1 9 18 10.1038/s41562-020-00996-4 33257880
Winterton A, et al. Improving the precision of intranasal oxytocin research. Nat Hum Behav. 2021;5(1):9–18.33257880 10.1038/s41562-020-00996-4
145. Mierop A How Can Intranasal Oxytocin Research Be Trusted? A Systematic Review of the Interactive Effects of Intranasal Oxytocin on Psychosocial Outcomes Perspect Psychol Sci 2020 15 5 1228 1242 10.1177/1745691620921525 32633663
Mierop A, et al. How Can Intranasal Oxytocin Research Be Trusted? A Systematic Review of the Interactive Effects of Intranasal Oxytocin on Psychosocial Outcomes. Perspect Psychol Sci. 2020;15(5):1228–42.32633663 10.1177/1745691620921525
146. Sabatier N α-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis J Neurosci 2003 23 32 10351 10358 10.1523/JNEUROSCI.23-32-10351.2003 14614094
Sabatier N, et al. α-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J Neurosci. 2003;23(32):10351–8.14614094 10.1523/JNEUROSCI.23-32-10351.2003
147. Mastinu A Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway Neuropharmacology 2018 133 366 374 10.1016/j.neuropharm.2018.02.007 29454840
Mastinu A, et al. Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway. Neuropharmacology. 2018;133:366–74.29454840 10.1016/j.neuropharm.2018.02.007
148. Pfaus JG Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist Proc Natl Acad Sci U S A 2004 101 27 10201 10204 10.1073/pnas.0400491101 15226502
Pfaus JG, et al. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci U S A. 2004;101(27):10201–4.15226502 10.1073/pnas.0400491101
149. Minakova E Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism PLoS ONE 2019 14 1 e0210389 10.1371/journal.pone.0210389 30629642
Minakova E, et al. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. PLoS ONE. 2019;14(1):e0210389.30629642 10.1371/journal.pone.0210389
150. Barrett CE Arambula SE Young LJ The oxytocin system promotes resilience to the effects of neonatal isolation on adult social attachment in female prairie voles Transl Psychiatry 2015 5 7 e606 10.1038/tp.2015.73 26196439
Barrett CE, Arambula SE, Young LJ. The oxytocin system promotes resilience to the effects of neonatal isolation on adult social attachment in female prairie voles. Transl Psychiatry. 2015;5(7):e606.26196439 10.1038/tp.2015.73
151. Ford CL Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner Neuropharmacology 2024 247 109848 10.1016/j.neuropharm.2024.109848 38253222
Ford CL, et al. Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner. Neuropharmacology. 2024;247:109848.38253222 10.1016/j.neuropharm.2024.109848
